FDA Approves Anjeso (meloxicam injection) for the Management of Moderate to Severe Pain

Article Link: FDA Approves Anjeso (meloxicam injection) for the Management of Moderate to Severe Pain

MALVERN, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug…

Source: FDA New Drug Approvals